samedan logo
home > ebr > summer 2020 > nova biomedical flex®2
European Biopharmaceutical Review

Nova Biomedical FLEX®2

Nova Biomedical is a technology company based in Waltham, Massachusetts, that provides state-of-the-art automated cell culture analysers for the biopharmaceutical market. In 1998, Nova introduced the first line of chemistry analysers for the biotechnology industry – the BioProfile® series. Nearly a decade later, Nova added the BioProfile Flex series featuring an expanded menu and real-time analysis of key metabolites, nutrients, and gases in cell culture media. In 2016, we announced the BioProfile FLEX2 analyser, which incorporates Nova’s maintenance-free MicroSensor™ Card technology that eliminates sensor maintenance and maximises workflow efficiency.

BioProfile analysers optimise and enhance process development, reliability, and reproducibility; improve manufacturing yield and quality; and reduce testing time and cost. In fact, BioProfile analysers can replace up to seven different instruments and measurement techniques while dramatically decreasing space requirements and capital equipment, labour, and reagent costs.

An optional On-Line Autosampler (OLS) allows users to connect multiple spinner flasks, bioreactors, and other vessels directly to the analyser and to establish user-defined sampling frequencies and feedback instructions for each reactor vessel. All results are stored in a data management system for subsequent retrieval or transmission to a data historian.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

Incorporated in 1976, Nova Biomedical is a world leader in development and manufacturing of whole blood point-of-care and critical care analysers, as well as the most advanced instruments for cell culture monitoring. One of the fastest growing in vitro diagnostic companies in the world, Nova’s biotechnology-specific BioProfile line provides over 20 critical cell culture tests with 12 unique instrument offerings for a broad range of cell culture applications. Nova employs over 1,300 people worldwide and has wholly owned subsidiaries located in Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, and Switzerland.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera and Noble announce collaboration to support patients who self-administer medication

Nemera is excited to leverage the new collaboration to expand end-to- end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices
More info >>

White Papers

How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction

Temptime Corporation

The specialty pharmacy industry could reduce costs by $27.5 million annually (product and call center staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage. In addition, 97% of patients surveyed, who received medicine from specialty pharmacies with a visual temperature indicator included in the package, agree that they would want an indicator in all shipments and 95% agree the indicator increased their confidence in the medicines received.
More info >>

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement